PIPER METHYSTICUM ROOT

PIPER METHYSTICUM ROOT was reported 23 times

PIPER METHYSTICUM ROOT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC INFLAMMATORY RESPONSE SYNDROME 1 0.0244
1 DELAYED SLEEP PHASE 1 0.0122
2 BACTERIAL VULVOVAGINITIS 1 0.0035
3 NASAL TURBINATE HYPERTROPHY 1 0.0027
4 EHLERS-DANLOS SYNDROME 1 0.0022
5 VITRECTOMY 1 0.0017
6 ISCHAEMIC HEPATITIS 2 0.0015
7 PNEUMONIA MYCOPLASMAL 1 0.0013
8 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
9 INFUSION SITE MASS 1 0.0009
10 RETROPERITONEAL HAEMORRHAGE 2 0.0008
11 SUBSTANCE USE 1 0.0006
12 BACTERIAL VAGINOSIS 1 0.0006
13 MEDICAL PROCEDURE 1 0.0006
14 INFUSION SITE DISCHARGE 1 0.0006
15 NASAL OBSTRUCTION 1 0.0005
16 NARCOLEPSY 1 0.0005
17 INFUSION SITE BRUISING 1 0.0005
18 INFECTIOUS MONONUCLEOSIS 1 0.0004
19 HYPOVOLAEMIC SHOCK 2 0.0004
20 ACUTE PSYCHOSIS 1 0.0004
21 INTESTINAL ISCHAEMIA 2 0.0004
22 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
23 INFUSION SITE HAEMORRHAGE 1 0.0003
24 TACHYPHRENIA 1 0.0003
25 RESPIRATORY ACIDOSIS 1 0.0003
26 FUNGAL SKIN INFECTION 1 0.0002
27 RHINITIS ALLERGIC 1 0.0002
28 ARTHRITIS INFECTIVE 1 0.0002
29 ROSACEA 1 0.0002
30 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
31 PHLEBITIS 1 0.0002
32 SINUS HEADACHE 1 0.0002
33 PRE-EXISTING CONDITION IMPROVED 1 0.0002
34 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
35 TROPONIN INCREASED 1 0.0001
36 FOOD ALLERGY 1 0.0001
37 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
38 DRUG SCREEN POSITIVE 1 0.0001
39 INFUSION SITE ERYTHEMA 1 0.0001
40 VITAMIN D DECREASED 1 0.0001
41 GASTROINTESTINAL INFECTION 1 0.0001
42 EXOSTOSIS 1 0.0001
43 HYPERCHOLESTEROLAEMIA 1 0.0001
44 DENTAL CARIES 1 0.0001
45 IMPAIRED DRIVING ABILITY 1 0.0001
46 BURSITIS 1 0.0001
47 INFUSION SITE PAIN 1 0.0001
48 TOOTH INFECTION 1 0.0001
49 ADVERSE REACTION 1 0.0001
50 ACUTE HEPATIC FAILURE 1 0.0001
51 INSURANCE ISSUE 1 0.0001
52 CYTOMEGALOVIRUS INFECTION 1 0.0001
53 CANDIDA INFECTION 1 0.0001
54 ORTHOSTATIC HYPOTENSION 1 0.0001
55 HEPATIC STEATOSIS 1 0.0001
56 BACTERIAL INFECTION 1 0.0001
57 FOOT FRACTURE 1 0.0001
58 SLEEP APNOEA SYNDROME 1 0.0001
59 SEROTONIN SYNDROME 1 0.0001
60 JOINT INJURY 1 0.0000
61 IMPAIRED WORK ABILITY 1 0.0000
62 DRUG RESISTANCE 1 0.0000
63 EAR INFECTION 1 0.0000
64 LACTIC ACIDOSIS 1 0.0000
65 VIRAL INFECTION 1 0.0000
66 FUNGAL INFECTION 1 0.0000
67 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
68 EXTRA DOSE ADMINISTERED 1 0.0000
69 COMPLETED SUICIDE 2 0.0000
70 RHABDOMYOLYSIS 1 0.0000
71 POLLAKIURIA 1 0.0000
72 SEPTIC SHOCK 1 0.0000
73 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
74 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
75 ECZEMA 1 0.0000
76 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
77 ARTHROPATHY 1 0.0000
78 CATARACT 1 0.0000
79 INFUSION RELATED REACTION 1 0.0000
80 BRONCHITIS 1 0.0000
81 DRUG INTERACTION 2 0.0000
82 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
83 COVID-19 2 0.0000
84 ADVERSE EVENT 1 0.0000
85 NASOPHARYNGITIS 2 0.0000
86 CONTUSION 1 0.0000
87 SOMNOLENCE 2 0.0000
88 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
89 INFLUENZA 1 0.0000
90 ASTHMA 1 0.0000
91 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
92 INFECTION 1 0.0000
93 BLOOD PRESSURE INCREASED 1 0.0000
94 ACUTE KIDNEY INJURY 1 0.0000
95 DRUG DEPENDENCE 1 0.0000
96 TOXICITY TO VARIOUS AGENTS 1 0.0000
97 URINARY TRACT INFECTION 1 0.0000
98 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
99 HYPERSENSITIVITY 1 0.0000
100 PRODUCT USE ISSUE 1 0.0000
101 GAIT DISTURBANCE 1 0.0000
102 ABDOMINAL PAIN UPPER 1 0.0000
103 DEPRESSION 1 0.0000
104 INCORRECT DOSE ADMINISTERED 1 0.0000
105 FEELING ABNORMAL 1 0.0000
106 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
107 OFF LABEL USE 3 0.0000
108 PRODUCT DOSE OMISSION ISSUE 1 0.0000
109 DIARRHOEA 2 0.0000
110 PNEUMONIA 1 0.0000
111 ARTHRALGIA 1 0.0000
112 DIZZINESS 1 0.0000
113 PAIN 1 0.0000
114 HEADACHE 1 0.0000
115 DRUG INEFFECTIVE 2 0.0000
116 FATIGUE 1 0.0000